An interventional study of Use of VirtuaCare™ for home program in Shoulder Disease and Shoulder Injuries, sponsored by Cedars-Sinai Medical Center. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-27.
Sponsored by Cedars-Sinai Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 39 studies in Shoulder Injuries with a site in United States — 14 open to participants now, 18 under way, none of them phase 3. Shoulder Injuries · United States.
Among the 39 studies in Shoulder Injuries with a site in United States, this one is the 23rd largest by planned enrollment of the 26 interventional ones that give a count, is one of 2 that started in 2024, is one of 20 with no phase, reaches primary completion later than 4 of the 17 other live ones, and was the 31st registered.
118 studies on the registry are indexed under Shoulder Injuries; 32 are open to participants now.
Browse Shoulder Injuries studies →14 of the 39 studies in Shoulder Injuries with a site in United States are open now. Recruiting first, the newest first:
Stryker Endoscopy · Sites in United States
Ages 18+
Stanford University · Sites in United States
Ages 18+
University of Maryland, Baltimore · Sites in United States
Ages 18–95 · Healthy volunteers
Duke University · Sites in United States
Ages 18–80
Zimmer Biomet · Sites in United States, Japan, New Zealand
Ages 20+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 17 Shoulder Injuries studies recruiting now, 8 (47%) set no upper age limit and 6 (35%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 55 across 69 interventional studies indexed under Shoulder Injuries.
Median enrollment 64 across the 26 interventional studies, 59 across the 13 observational. Of the 20 that completed or were terminated, 5 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 39 have an industry lead sponsor. The 10 most frequent:
Cedars-Sinai Medical Center is the lead sponsor of 457 studies on the registry; 108 are open to participants now.
Of its 65 completed or terminated interventional studies of FDA-regulated products, 49 (75%) have results posted.
Cedars-Sinai Medical Center has 1 study filed under Shoulder Injuries — fewer than ten, so there is no comparison to draw.
7 of the studies in Shoulder Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06016257Cedars-Sinai Medical CenterUsing VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study | 2026-12-31 |
| NCT04109638Stanford UniversityPulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery | 2027-02 |
| NCT05344898University of Maryland, BaltimoreSubscap Reverse Shoulder Arthroplasty | 2027-05-15 |
| NCT02600910The University of Texas Medical Branch, GalvestonNatural History of Shoulder Pathology in Manual Wheelchair Users | 2027-06 |
| NCT06501859University of UtahRehabilitation With the Shoulder Pacemaker | 2027-07 |
Add all 7 to your calendar (.ics) → With an account.
Among the 39 studies in Shoulder Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will be performed to determine if Band Connect's VirtuaCare™ platform increases patient compliance and provides an effective alternative to current physical therapy treatment while reducing the frequency of visits compared with standard orthopedic physical therapy treatment performed in the outpatient clinic.
Participants are being asked to take part in this research study if 18 years and older and have been prescribed physical therapy rehabilitation for an acute or chronic shoulder condition and as part of the participant's physical therapy will receive a shoulder exercise home program.
In today's environment, review of a patient's rehabilitation progress and recovery is limited to in-person, one-on-one clinic visits with their therapist periodically. While these sessions are typically well-defined and comprehensive, there are no mechanisms currently available to help the clinicians and therapists to effectively engage with patients when they are not in the clinic.
Patients are prescribed at-home exercises after each visit and the therapists have no line of sight as to how the patient is progressing or if the patient is even adhering to the treatment plan. The patient typically receives some rudimentary instruction about how an exercise or treatment needs to be performed, a setup that can result in unknown adherence and/or poor form. There are also no mechanisms for active feedback to the patient about any aspect of their treatment of recovery - e.g., whether the patient is doing better or worse. These gaps and inconsistencies result in a circumstance wherein less than 35% of patients typically adhere to their prescribed plans of care.
Patient Adherence Today, it is estimated that while 64% of physical therapy patients comply with short-term exercise regimens, only 23% preserve adherence throughout their physical therapy treatment. While this number seems accurate, these percentages are still unknown because patients typically do not admit non-compliance and adherence is typically not measured objectively [6]. Results from a study examining at-home adherence for patients with chronic low back pain indicate that barriers include "the exercise program (number, effectiveness, complexity and burden of exercises), the healthcare journey (breakdown between supervised sessions and home exercise, lack of follow-up and difficulties in contacting care providers), patient representations (illness and exercise perception, despondency, depression and lack of motivation), and the environment (attitudes of others, difficulties in planning exercise practice) [4]." Conversely, the study found that opportunities to increase adherence include improving patient performance through feedback capabilities and increased support from care providers. The study concluded that new technologies have the potential to meet these barriers and are attractive to patients but only if the technology is not a substitute for in-person relationship between the patients and care providers [4]. Unlike technologies currently on the market that focus solely on virtual environments, the VirtuaCare™ platform provides a tool for physical therapists to supplement their in-person treatment with a higher-caliber experience outside of the clinic environment.
Band Connect will address some of these constraints by using digital health technology in conjunction with a personalized simulation of each exercise, allowing patients to adopt the correct form, review progress, and receive continuous real-time instruction through a visual mechanism. Additionally, the physical therapist can remotely review the patient's progress on the platform in an objective manner and adjust their treatment plan accordingly.
This study, specifically, will focus both on measuring the effectiveness of VirtuaCare™ to drive towards higher adherence rates while providing the usual and customary orthopedic physical therapy with a platform that allows for lower frequency of in-clinic visits over the typical outpatient rehabilitation duration. This is an incredibly relevant and important consideration in the current healthcare environment.
This study will be performed to determine if Band Connect's VirtuaCare™ platform increases patient adherence and provides equivalency to current physical therapy treatment while reducing frequency of visits compared with standard orthopedic physical therapy treatment performed in the outpatient clinic The study will measure and collate a variety of data points with patients using VirtuaCare™ and compare these to a historical control group of patients with the same orthopedic conditions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Physical therapy home program subjects
Patients who had usual and customary treatment for acute and chronic shoulder conditions
Exclusion Criteria:
Physical therapy home program subjects
Physical therapists • Any therapist who does not provide physical therapy treatment for acute and chronic shoulder conditions.
Patients who had usual and customary treatment for acute and chronic shoulder conditions
For the subjects in Group 1, the physical therapist will set up the patients within the VirtuaCare™ system and build their treatment plan. Each time a patient in the VirtuaCare returns for a clinic visit, the physical therapist will review their VirtuaCare™ patient report displaying information such as exercises completed along with their measured form, pace, range of motion, and exertion. From the review, they will help the patient understand any corrections they need to make in the following week when at home. The therapist can add or adjust any exercises they deem necessary for the next phase of the patient's rehabilitation.
Other: Use of VirtuaCare™ for home program
This study involves a medical record review for the control group. Data will be abstracted from closed medical records after completion of shoulder physical therapy.
Use of VirtuaCare™ system for the Home Program.
Reduced Number of Visits
Number of participants treatment visits using the VirtuaCare™ platform compared to usual and customary physical therapy treatment
Time frame: 4-8 weeks
Improved Functional outcome
Participants score on the Upper Extremity Functional Index using the VirtuaCare™ platform compared to usual and customary physical therapy treatment score on the Upper Extremity Functional Index (UEFI). Scores range from 0 to 4, 0 indicates extreme difficulty while 4 indicates no difficulty with a task. Possible range on the 20-item UEFI is from 0-80 with 0 indicating lowest functional status and 80 indicating highest functional status. The higher the score, the better the functional status. The minimum amount of change that is considered to be clinically significant is 9 points.
Time frame: 4-8 weeks
Home Program Adherence
The participant's number of times to perform the home program as prescribed.
Time frame: 4-8 weeks
Therapist Feasibility
The therapist's score on feasibility instrument using the VirtuaCare™ platform. The scores range from 1 strongly agree to 5 strongly disagree. The lower the score the better.
Time frame: Within one month of the participant's last visit.
Plan to share: No — No plan to share data except with patient during treatment
No publications or documents are linked to this record.
Started Feb 2024 (actual). Primary completion is estimated for Dec 2026, 34 months after the start.
Of 38 non-industry interventional studies with no phase under Shoulder Injuries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 45. This study's planned 34 months is above that.
Counting every sponsor, half of 43 studies reached it within 15 months; a quarter within 7 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.